As already observed in previous studies [22,23], the administration of TG68 in HFD-fed mice lowered the serum levels of ALT and AST, revealing that, in addition to revert a condition of simple steatosis, it may also efficiently ameliorate the background of cell death typical of NASH. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.